JAK2 and breast cancer: At signaling level, it has been reported that even if Jak2 is essential for the proliferative effects of PRL in the onset of induced mammary tumorigenesis, the deletion of Jak2 following neoplastic transformation had no significant impact on the survival and growth of mammary cancer cells in culture and in vivo[45].